Sumary of COVID-19 has transformed the world of vaccines:
- Labs worldwide had the ability to make genomic vaccines before COVID-19 Related Stories By the moment the genomic sequence for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for COVID-19 – was made publicly available on the internet
- Difficile, Clostridium difficile; GBS, faction B Streptococcus; HSV1, herpes simplex virus 1; HSV2, herpes simplex virus 2; HHV, 6-7 mankind herpes viruses 6 and 7; CMV, cytomegalovirus; EBV, Epstein-Barr virus; HIV, mankind immunodeficiency virus; HCV, hepatitis C virus.
- The group says the pandemic has fast-forwarded the development of technologies such as synthetic RNA vaccines and viral vectors by at least a decade.
- For example, bacteria that are resistant to antibiotics pose a significant public health threat, with people potentially vulnerable to recurrent infection with pathogens such as Escherichia coli, Staphylococcus aureus, Clostridium difficile, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
“It is possible that evolution of the new technologies fast-tracked for COVID-19 (RNA vaccines, viral vectors, and protein-based vaccines with potent adjuvants) combined with the learning coming from immunotherapy will be the answer for some of the new challenges of modern society such as emerging infections, AMR, chronic infections, and cancer,” concludes the team.